Cargando…

A Biomimetic, Silaffin R5-Based Antigen Delivery Platform

Nature offers a wide range of evolutionary optimized materials that combine unique properties with intrinsic biocompatibility and that can be exploited as biomimetic materials. The R5 and RRIL peptides employed here are derived from silaffin proteins that play a crucial role in the biomineralization...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichinger, Daniela, Reithofer, Manuel, Hohagen, Mariam, Drinic, Mirjana, Tobias, Joshua, Wiedermann, Ursula, Kleitz, Freddy, Jahn-Schmid, Beatrice, Becker, Christian F. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866965/
https://www.ncbi.nlm.nih.gov/pubmed/36678751
http://dx.doi.org/10.3390/pharmaceutics15010121
_version_ 1784876224504397824
author Reichinger, Daniela
Reithofer, Manuel
Hohagen, Mariam
Drinic, Mirjana
Tobias, Joshua
Wiedermann, Ursula
Kleitz, Freddy
Jahn-Schmid, Beatrice
Becker, Christian F. W.
author_facet Reichinger, Daniela
Reithofer, Manuel
Hohagen, Mariam
Drinic, Mirjana
Tobias, Joshua
Wiedermann, Ursula
Kleitz, Freddy
Jahn-Schmid, Beatrice
Becker, Christian F. W.
author_sort Reichinger, Daniela
collection PubMed
description Nature offers a wide range of evolutionary optimized materials that combine unique properties with intrinsic biocompatibility and that can be exploited as biomimetic materials. The R5 and RRIL peptides employed here are derived from silaffin proteins that play a crucial role in the biomineralization of marine diatom silica shells and are also able to form silica materials in vitro. Here, we demonstrate the application of biomimetic silica particles as a vaccine delivery and adjuvant platform by linking the precipitating peptides R5 and the RRIL motif to a variety of peptide antigens. The resulting antigen-loaded silica particles combine the advantages of biomaterial-based vaccines with the proven intracellular uptake of silica particles. These particles induce NETosis in human neutrophils as well as IL-6 and TNF-α secretion in murine bone marrow-derived dendritic cells.
format Online
Article
Text
id pubmed-9866965
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98669652023-01-22 A Biomimetic, Silaffin R5-Based Antigen Delivery Platform Reichinger, Daniela Reithofer, Manuel Hohagen, Mariam Drinic, Mirjana Tobias, Joshua Wiedermann, Ursula Kleitz, Freddy Jahn-Schmid, Beatrice Becker, Christian F. W. Pharmaceutics Article Nature offers a wide range of evolutionary optimized materials that combine unique properties with intrinsic biocompatibility and that can be exploited as biomimetic materials. The R5 and RRIL peptides employed here are derived from silaffin proteins that play a crucial role in the biomineralization of marine diatom silica shells and are also able to form silica materials in vitro. Here, we demonstrate the application of biomimetic silica particles as a vaccine delivery and adjuvant platform by linking the precipitating peptides R5 and the RRIL motif to a variety of peptide antigens. The resulting antigen-loaded silica particles combine the advantages of biomaterial-based vaccines with the proven intracellular uptake of silica particles. These particles induce NETosis in human neutrophils as well as IL-6 and TNF-α secretion in murine bone marrow-derived dendritic cells. MDPI 2022-12-29 /pmc/articles/PMC9866965/ /pubmed/36678751 http://dx.doi.org/10.3390/pharmaceutics15010121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Reichinger, Daniela
Reithofer, Manuel
Hohagen, Mariam
Drinic, Mirjana
Tobias, Joshua
Wiedermann, Ursula
Kleitz, Freddy
Jahn-Schmid, Beatrice
Becker, Christian F. W.
A Biomimetic, Silaffin R5-Based Antigen Delivery Platform
title A Biomimetic, Silaffin R5-Based Antigen Delivery Platform
title_full A Biomimetic, Silaffin R5-Based Antigen Delivery Platform
title_fullStr A Biomimetic, Silaffin R5-Based Antigen Delivery Platform
title_full_unstemmed A Biomimetic, Silaffin R5-Based Antigen Delivery Platform
title_short A Biomimetic, Silaffin R5-Based Antigen Delivery Platform
title_sort biomimetic, silaffin r5-based antigen delivery platform
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866965/
https://www.ncbi.nlm.nih.gov/pubmed/36678751
http://dx.doi.org/10.3390/pharmaceutics15010121
work_keys_str_mv AT reichingerdaniela abiomimeticsilaffinr5basedantigendeliveryplatform
AT reithofermanuel abiomimeticsilaffinr5basedantigendeliveryplatform
AT hohagenmariam abiomimeticsilaffinr5basedantigendeliveryplatform
AT drinicmirjana abiomimeticsilaffinr5basedantigendeliveryplatform
AT tobiasjoshua abiomimeticsilaffinr5basedantigendeliveryplatform
AT wiedermannursula abiomimeticsilaffinr5basedantigendeliveryplatform
AT kleitzfreddy abiomimeticsilaffinr5basedantigendeliveryplatform
AT jahnschmidbeatrice abiomimeticsilaffinr5basedantigendeliveryplatform
AT beckerchristianfw abiomimeticsilaffinr5basedantigendeliveryplatform
AT reichingerdaniela biomimeticsilaffinr5basedantigendeliveryplatform
AT reithofermanuel biomimeticsilaffinr5basedantigendeliveryplatform
AT hohagenmariam biomimeticsilaffinr5basedantigendeliveryplatform
AT drinicmirjana biomimeticsilaffinr5basedantigendeliveryplatform
AT tobiasjoshua biomimeticsilaffinr5basedantigendeliveryplatform
AT wiedermannursula biomimeticsilaffinr5basedantigendeliveryplatform
AT kleitzfreddy biomimeticsilaffinr5basedantigendeliveryplatform
AT jahnschmidbeatrice biomimeticsilaffinr5basedantigendeliveryplatform
AT beckerchristianfw biomimeticsilaffinr5basedantigendeliveryplatform